Clinical trials
Observational Urinary Bladder Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 10 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
| Unknown status | 18 |
| Completed | 10 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 9 |
| Changhai Hospital | 4 |
| Qilu Hospital of Shandong University | 4 |
| The First Affiliated Hospital with Nanjing Medical University | 4 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| Huazhong University of Science and Technology | 2 |
| Wuhan Ammunition Life-tech Co., Ltd | 2 |
| AnchorDx Medical Co., Ltd. | 1 |
| AstraZeneca | 1 |
| Creative Biosciences (Guangzhou) Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 50 |
| Carcinoma, Transitional Cell | 8 |
| Disease | 4 |
| Colorectal Neoplasms | 3 |
| Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Esophageal Neoplasms | 2 |
| Hematuria | 2 |
| Liver Neoplasms | 2 |
| Lung Neoplasms | 2 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.